जौगालु हादोरफोराव, जेराव HAART या थोजासे, जागायजेननाय सिकितसाखौ माब्ला गनायथिनो थिरांथा खालामनाय समाव, दाकतारफोरा भाइरेल बिबां, CD4 खामायनायनि गोख्रैथि आरो बेरामि जागायजेननायखौ नायबिजिरो।
In developed countries where HAART is available, doctors assess the viral load, rapidity in CD4 decline, and patient readiness while deciding when to recommend initiating treatment.